Ming Zhang,Raffaele Ferrari,Maria Carmela Tartaglia,Julia Keith,Ezequiel I. Surace,Uri Wolf,Christine Sato,Mark Grinberg,Yan Liang,Zhengrui Xi,Kyle Dupont,Philip McGoldrick,Anna Weichert,Paul M. McKeever,Raphael Schneider,Michael D. McCorkindale,Claudia Manzoni,Rosa Rademakers,Neill R. Graff-Radford,Dennis W. Dickson,Joseph E. Parisi,Bradley F. Boeve,Ronald C. Petersen,Bruce L. Miller,William W. Seeley,John C. van Swieten,Jeroen van Rooij,Yolande Pijnenburg,Julie van der Zee,Christine Van Broeckhoven,Isabelle Le Ber,Vivianna Van Deerlin,EunRan Suh,Jonathan D. Rohrer,Simon Mead,Caroline Graff,Linn Oijerstedt,Stuart Pickering-Brown,Sara Rollinson,Giacomina Rossi,Fabrizio Tagliavini,William S. Brooks,Carol Dobson-Stone,Glenda M. Halliday,John R. Hodges,Olivier Piguet,Giuliano Binetti,Luisa Benussi,Roberta Ghidoni,Benedetta Nacmias,Sandro Sorbi,Amalia C. Bruni,Daniela Galimberti,Elio Scarpini,Innocenzo Rainero,Elisa Rubino,Jordi Clarimon,Alberto Lleo,Agustin Ruiz,Isabel Hernandez,Pau Pastor,Monica Diez-Fairen,Barbara Borroni,Florence Pasquier,Vincent Deramecourt,Thibaud Lebouvier,Robert Perneczky,Janine Diehl-Schmid,Jordan Grafman,Edward D. Huey,Richard Mayeux,Michael A. Nalls,Dena Hernandez,Andrew Singleton,Parastoo Momeni,Zhen Zeng,John Hardy,Janice Robertson,Lorne Zinman,Ekaterina Rogaeva

Abstract:The G4C2-repeat expansion in C9orf72 is the most common known cause of amyotrophic lateral sclerosis and frontotemporal dementia. The high phenotypic heterogeneity of C9orf72 patients includes a wide range in age of onset, modifiers of which are largely unknown. Age of onset could be influenced by environmental and genetic factors both of which may trigger DNA methylation changes at CpG sites. We tested the hypothesis that age of onset in C9orf72 patients is associated with some common single nucleotide polymorphisms causing a gain or loss of CpG sites and thus resulting in DNA methylation alterations. Combined analyses of epigenetic and genetic data have the advantage of detecting functional variants with reduced likelihood of false negative results due to excessive correction for multiple testing in genome-wide association studies. First, we estimated the association between age of onset in C9orf72 patients (n = 46) and the DNA methylation levels at all 7603 CpG sites available on the 450 k BeadChip that are mapped to common single nucleotide polymorphisms. This was followed by a genetic association study of the discovery (n = 144) and replication (n = 187) C9orf72 cohorts. We found that age of onset was reproducibly associated with polymorphisms within a 124.7 kb linkage disequilibrium block tagged by top-significant variation, rs9357140, and containing two overlapping genes (LOC101929163 and C6orf10). A meta-analysis of all 331 C9orf72 carriers revealed that every A-allele of rs9357140 reduced hazard by 30% (P = 0.0002); and the median age of onset in AA-carriers was 6 years later than GG-carriers. In addition, we investigated a cohort of C9orf72 negative patients (n = 2634) affected by frontotemporal dementia and/or amyotrophic lateral sclerosis; and also found that the AA-genotype of rs9357140 was associated with a later age of onset (adjusted P = 0.007 for recessive model). Phenotype analyses detected significant association only in the largest subgroup of patients with frontotemporal dementia (n = 2142, adjusted P = 0.01 for recessive model). Gene expression studies of frontal cortex tissues from 25 autopsy cases affected by amyotrophic lateral sclerosis revealed that the G-allele of rs9357140 is associated with increased brain expression of LOC101929163 (a non-coding RNA) and HLA-DRB1 (involved in initiating immune responses), while the A-allele is associated with their reduced expression. Our findings suggest that carriers of the rs9357140 GG-genotype (linked to an earlier age of onset) might be more prone to be in a pro-inflammatory state (e.g. by microglia) than AA-carriers. Further, investigating the functional links within the C6orf10/LOC101929163/HLA-DRB1 pathway will be critical to better define age-dependent pathogenesis of frontotemporal dementia and amyotrophic lateral sclerosis.

Fibroblasts carrying intermediate C9orf72 hexanucleotide repeat expansions from iNPH patients show impaired energy metabolism but no cell pathologies

C9orf72 repeat expansion-carrying iPSC-microglia from FTD patients show increased phagocytic activity concomitantly with decreased number of autophagosomal-lysosomal vesicles

Glucose hypometabolism prompts RAN translation and exacerbates C9orf72-related ALS/FTD phenotypes

Frontotemporal dementia patient-derived iPSC neurons show cell pathological hallmarks and evidence for synaptic dysfunction and DNA damage

Elevated Cerebrospinal Fluid Ubiquitin Carboxyl‐Terminal Hydrolase Isozyme L1 in Asymptomatic C9orf72 Hexanucleotide Repeat Expansion Carriers

Cerebellar integrity and contributions to cognition in C9orf72-mediated frontotemporal dementia

C9orf72 is differentially expressed in the central nervous system and myeloid cells and consistently reduced in C9orf72, MAPT and GRN mutation carriers

Myelin loss in C9orf72 hexanucleotide expansion carriers

Cerebellar C9ran Proteins Associate with Clinical and Neuropathological Characteristics of C9ORF72 Repeat Expansion Carriers

C9orf72 Expansion Creates the Unstable Folate-Sensitive Fragile Site FRA9A

C9orf72 ALS-FTD: recent evidence for dysregulation of the autophagy-lysosome pathway at multiple levels

C9orf72 gene networks in the human brain correlate with cortical thickness in C9-FTD and implicate vulnerable cell types

Distribution of the C9orf72 hexanucleotide repeat expansion in healthy subjects: a multicenter study promoted by the Italian IRCCS network of neuroscience and neurorehabilitation

Novel Clinical Associations with Specific C9ORF72 Transcripts in Patients with Repeat Expansions in C9ORF72.

The clinical and pathological phenotypes of frontotemporal dementia with C9ORF72 mutations.

Moderate intrinsic phenotypic alterations in C9orf72 ALS/FTD iPSC-microglia despite the presence of C9orf72 pathological features

Unaffected mosaic C9orf72 case: RNA foci, dipeptide proteins, but upregulated C9orf72 expression.

Atypical Electropherogram Patterns are Observed Among C9orf72 (G4C2) Expansion Carriers in a Familial and Sporadic ALS and ALS/FTD North American Cohort Study (P5.056)

A C6orf10/LOC101929163 Locus is Associated with Age of Onset in C9orf72 Carriers.

Pathological mitochondria in neurons and perivascular astrocytic endfeet of idiopathic normal pressure hydrocephalus patients

TFEB/Mitf links impaired nuclear import to autophagolysosomal dysfunction in C9-ALS